Leading expert in liver diseases, Dr. Simon Robson, MD, explains how to prevent and treat chronic liver conditions. He details the rising epidemic of nonalcoholic fatty liver disease and steatohepatitis. Early diagnosis is critical for autoimmune liver disease and metabolic storage disorders. Dr. Simon Robson, MD, emphasizes lifestyle changes and the importance of medical second opinions. Effective treatments now exist for viral hepatitis B and C.
More from Diagnostic Detectives Network
Modern Strategies for Chronic Liver Disease Prevention and Treatment
Jump To Section
- Nonalcoholic Fatty Liver Disease Epidemic
- Autoimmune Liver Disease Diagnosis
- Metabolic Storage Liver Disorders
- Viral Hepatitis Treatment Advances
- Alcoholic Liver Disease Challenges
- Prevention and Early Intervention
- Full Transcript
Nonalcoholic Fatty Liver Disease Epidemic
Nonalcoholic fatty liver disease (NAFLD) represents a major and growing health crisis. Dr. Simon Robson, MD, identifies it as a primary concern linked to diabetes and obesity. This condition can progress to steatohepatitis, which is liver inflammation in the presence of fat. Patients are often morbidly obese and have Type 2 diabetes. The best prevention addresses the underlying metabolic problems that lead to NAFLD.
Autoimmune Liver Disease Diagnosis
Early diagnosis of autoimmune liver disease is absolutely critical. Dr. Simon Robson, MD, warns that a missed or delayed diagnosis can have severe consequences. Without timely immunosuppressive treatment, patients can progress to liver cirrhosis, liver failure, and death. This form of liver disease can present as a manifestation of rheumatic disease or inflammatory bowel disease. Liver transplantation remains the only option at an advanced stage.
Metabolic Storage Liver Disorders
Several metabolic disorders cause significant liver damage. Dr. Simon Robson, MD, highlights iron storage disease (hemochromatosis) and copper storage disease (Wilson's disease). He also mentions alpha-1 antitrypsin deficiency and glycogen storage diseases. While these conditions are rarer than NAFLD, their frequency is increasing as viral hepatitis becomes more treatable. Early diagnosis of these storage disorders is vital for effective intervention.
Viral Hepatitis Treatment Advances
Modern medicine now offers potential cures for hepatitis B and hepatitis C. Dr. Simon Robson, MD, notes this is a monumental shift in hepatology. The incidence of end-stage liver disease and liver cancer caused by these viruses is expected to decrease. Dr. Anton Titov, MD, and Dr. Robson discuss how this changes the landscape of chronic liver disease. Vaccination against Hepatitis A and B remains a cornerstone of prevention.
Alcoholic Liver Disease Challenges
Alcoholic liver disease remains a persistent and growing problem. Dr. Robson points to dramatically increasing rates of alcoholism in North America and Europe. A significant challenge is the lack of effective therapies for alcoholism itself. There are also minimal antidotes to prevent ongoing liver injury in patients who continue heavy drinking. This area requires greater public health focus and research.
Prevention and Early Intervention
Chronic liver disease treatment hinges on early diagnosis and lifestyle modification. Dr. Simon Robson, MD, stresses that treatment starts with simple but important steps. Dietary changes and addressing metabolic health are fundamental for NAFLD. Dr. Anton Titov, MD, emphasizes the value of a medical second opinion to confirm a diagnosis and choose the best treatment. This proactive approach can prevent deterioration to cirrhosis and liver cancer.
Full Transcript
Dr. Anton Titov, MD: Chronic liver disease treatment focuses on simple but important steps. Leading expert in liver diseases describes how to best prevent and treat chronic liver diseases, steatohepatitis, and autoimmune liver disease.
How to stop chronic liver disease deterioration to cirrhosis and liver cancer? Chronic liver disease treatment is improving.
Video interview with leading expert in liver diseases, Dr. Simon Robson, MD. Nonalcoholic fatty liver disease treatment is based on early diagnosis. Chronic liver disease treatment is important to start as early as possible. Steatohepatitis is an early sign of fatty liver disease.
Medical second opinion helps to make sure diagnosis of chronic liver disease is correct and complete. Medical second opinion also helps to choose the best treatment for chronic liver disease and viral hepatitis.
Medical second opinion in autoimmune liver disease and rheumatological liver disorder. Iron storage (hemochromatosis) and copper storage (Wilson's disease) liver diseases increase in frequency.
Dr. Simon Robson, MD: Chronic liver disease treatment is focused on lifestyle change and food habit changes to avoid further damage to liver. It is important to recognize and treat autoimmune liver disease as early as possible.
Late diagnosis of autoimmune liver disease leads to liver cirrhosis and liver failure. Chronic liver disease treatment is based on early diagnosis and dietary modifications.
Treatment of chronic liver disease. We have potential cure for hepatitis B and hepatitis C. End-stage liver disease and liver cancer from viral hepatitis is going to decrease.
Dr. Anton Titov, MD: What are the other major liver diseases that will be prominent in the future?
Dr. Simon Robson, MD: Diabetes, obesity and nonalcoholic fatty liver disease is a major epidemic that we are going to see. Nonalcoholic fatty liver disease can progress to inflammation. We then call it steatohepatitis.
Steatohepatitis simply means "liver inflammation in the presence of fat". Many patients with steatohepatitis can worsen. Patients can suddenly present with liver cirrhosis.
Patients with nonalcoholic fatty liver disease and steatohepatitis also can first present with complications of cirrhosis. They can have liver cancer.
Patients are predisposed to nonalcoholic fatty liver disease and steatohepatitis. They are usually morbidly obese. They often have diabetes.
Such patients are often treated with medications to treat Type 2 diabetes. Patients take oral hypoglycemic medications. There is not much we can do to preclude the development of nonalcoholic fatty liver disease (NAFLD) and steatohepatitis.
The best prevention is to address the fundamental metabolic problems that lead to NAFLD and steatohepatitis.
Other major form of liver disease is autoimmune liver disease. It can present as liver manifestation of rheumatic disease (rheumatological liver disorder). Autoimmune liver disease can also present as inflammatory bowel disease or celiac disease.
Early diagnosis of autoimmune liver disease is important. Because we could miss correct diagnosis. We could fail to treat the patient with immunosuppressive medications.
Patients can progress to liver cirrhosis, liver failure and death. Liver transplantation is the only treatment at advanced stage of autoimmune liver disease.
We still see liver inflammation associated with metabolic disorders. Alpha-1 antitrypsin deficiency is one example of liver inflammation disorder.
We also see liver problems associated with iron storage (hemochromatosis) and copper storage (Wilson's disease). We also see liver diseases that are caused by problems with glycogen storage (glycogen storage diseases). Glycogen is animal starch.
Iron storage disease, Wilson disease, and glycogen storage diseases are much more rare. Nonalcoholic fatty liver disease and steatohepatitis are more common.
I have spoken of viral hepatitis B and hepatitis C. Other forms of liver disease are increasing in frequency. Because we can now treat more effectively hepatitis C and hepatitis B.
Nonalcoholic fatty liver disease, steatohepatitis and diabetes are increasing. Diabetes is also rising. Alcoholic liver disease is a problem in North America and Europe.
Dr. Anton Titov, MD: Rates of alcoholism and alcohol usage are increasing dramatically. There are few effective therapies for alcoholism.
Dr. Simon Robson, MD: There are minimal antidotes to prevent liver injury if patients continue to drink alcohol heavily. We will discuss alcohol liver disease later in the interview.
We will discuss nutrition, toxins and liver disease. It is important that we immunize patients against Hepatitis B and Hepatitis A. We have vaccines against Hepatitis B and Hepatitis A.
It is important to diagnose other liver diseases early, such as iron overload (hemochromatosis). Early diagnosis of copper storage disorders (Wilson's disease, Wilson disease) is important.
It is important to make early diagnosis of autoimmune liver disease associated with inflammatory bowel disease. Not only viruses cause hepatitis.
Many other diseases cause liver inflammation. Many other disorders can damage the liver.
Dr. Anton Titov, MD: Video interview with leading expert in liver diseases. Autoimmune liver disease, steatohepatitis, iron and copper storage disease.